Dr Vivienne Nathanson: These firms have a vested interest in boosting sales
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.We badly need an alcohol strategy, but executives from the drinks industry are not the people we want writing it.
It is worrying that the industry has so many people involved in a group that is supposed to be advising the Government on alcohol policy. These are people with a vested interest in keeping sales high. They don't want alcohol associated with violence in the street, but they also don't want to lower their bottom line. That's why the strategy needs to be written, and only then should the industry be approached for its views.
The central problem is that people who understand the health problems associated with alcohol want to see something like a 40 per cent cut in sales. The drinks industry is obviously opposed to that. Price, promotion and availability are key to an alcohol strategy. The industry hates that. They say we are hung up on price. And yes, we are: the global evidence is that price matters.
Marketing too. If people see adverts suggesting alcohol is associated with success they are going to see alcohol as a desirable product and a normal product. We have to challenge that.
The writer is head of science and ethics at the British Medical Association
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments